Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-β1 or PDGF-BB as assayed in vivo and in vitro
Open Access
- 1 September 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 11 (9) , 1264-1273
- https://doi.org/10.1002/jbmr.5650110911
Abstract
Mesenchymal progenitors cells can be isolated from rat bone marrow and mitotically expanded in vitro. When these cells, which we operationally call mesenchymal stem cells (MSCs), are placed in an appropriate environment, they have the capacity to differentiate into bone and/or cartilage. This capacity is called osteochondrogenic potential. In this study, preconfluent MSCs were exposed in vitro to 5 ng/ml transforming growth factor-β1 (TGF-β1) or platelet-derived growth factor, isoform BB (PDGF-BB) for a pulse of 48 h and assayed for cell proliferation, alkaline phosphatase activity, and osteochondrogenic potential; untreated MSC's served as controls. In these cell culture conditions, TGF-β1 or PDGF-BB had similar effects on proliferation and alkaline phosphatase activity. Both growth factors increased cell proliferation and decreased alkaline phosphatase activity of MSCs. Sister cultures of TGF-β1- or PDGF-BB-treated MSCs and untreated MSCs were trypsinized. For each type of culture, the trypsinised MSCs were split in two parts: one part was replated in an osteogenic medium to assess its in vitro osteogenic potential, whereas the other part was seeded into porous calcium phosphate ceramics and implanted subcutaneously in syngeneic rats to assess its in vivo osteochondrogenic potential. PDGF-pretreated MSCs showed no difference in in vivo and in vitro osteochondrogenesis from that of control MSCs, while TGF-β1 pretreatment blocked the osteochondrogenic potential of MSCs when assayed in vitro for bone nodule formation. However, when tested in vivo, TGF-β1-pretreated MSCs were able to form bone and cartilage. These data show that measurements of proliferation and alkaline phosphatase activity of preconfluent MSCs immediately after exposure to growth factor were not predictive of their subsequent osteochondrogenic potential. Moreover, the variation of the osteochondrogenic potential of MSCs after exposure to growth factor was further modulated by the environment in which the MSCs were assayed.Keywords
Funding Information
- University of Bordeaux II, France
- Howard Hughes, Department of Biology
- Cleveland Chapter of the American Cancer Society (NIH (#DE 97220))
This publication has 39 references indexed in Scilit:
- A Chemically Defined Medium Supports in Vitro Proliferation and Maintains the Osteochondral Potential of Rat Marrow-Derived Mesenchymal Stem CellsExperimental Cell Research, 1995
- Interleukin 10 inhibits transforming growth factor-beta (TGF-beta) synthesis required for osteogenic commitment of mouse bone marrow cellsThe Journal of cell biology, 1994
- Transforming growth factor ?1-induced cellular heterogeneity in the periosteum of rat parietal bonesCalcified Tissue International, 1993
- Characterization of cells with osteogenic potential from human marrowBone, 1992
- The Microvasculature of the Human Bone Marrow Correlated with the Distribution of Hematopoietic Cells. A Computer-Assisted Three-Dimensional Reconstruction Study.The Tohoku Journal of Experimental Medicine, 1992
- Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramicBiomaterials, 1991
- Bone Growth FactorsClinical Orthopaedics and Related Research, 1991
- Effects of platelet‐derived growth factor on bone formation in vitroJournal of Cellular Physiology, 1989
- Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone‐like nodules in vitroFEBS Letters, 1989
- Accumulation, localization, and compartmentation of transforming growth factor beta during endochondral bone development.The Journal of cell biology, 1988